Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Idea to Innovation

McGill University

$20,000.00

Market Assessment: Market analysis for monitoring gout disease at the point of need using a CMOS-based device

FY 2021-22

Summary
In our lab we developed a novel portable biosensor for uric acid detection via electrochemiluminescence. The product includes a sensing platform based on a Complementary metaloxide-semiconductor (CMOS) chip, a reader, and a vial of reaction buffer to mix with the target sample for chemiluminescence reaction. It can be used to track the level of uric acid and monitor for early signs of gout. The prevalence and incidence of gout are increasing worldwide. Approximately 5.2% of Canadian males and 2.4% of Canadian females are affected by gout, and the incidence of this disease increases with age. Therefore, it is important for people with gout disease or at high risk of gout disease to monitor their level of uric acid. Within the frame of this proposal, we will perform a market analysis to identify the potential of our device to compete with existing technologies available on the market. Market size, user-derived design specifications will be obtained for interactions with end users. Once the market analysis is completed, we will decide on the next steps, such as to move to the next phase of pilot testing and prototyping, and starting up a company. Overall, if successful, the project will allow for the development of novel technology for individuals suffering from gout disease, leading to an improved quality of life and lower disability adjusted life years.
Program
Idea to Innovation
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
571239-2022
Name nom
Wachsmann-Hogiu, Sebastian
Department département
Bioengineering
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2022
Award amount
20000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Installment
inst:1
Partie
1
Nb partie
1
Application title
Market Assessment: Market analysis for monitoring gout disease at the point of need using a CMOS-based device
Keyword
NSERC
Application summary
In our lab we developed a novel portable biosensor for uric acid detection via electrochemiluminescence. The product includes a sensing platform based on a Complementary metaloxide-semiconductor (CMOS) chip, a reader, and a vial of reaction buffer to mix with the target sample for chemiluminescence reaction. It can be used to track the level of uric acid and monitor for early signs of gout. The prevalence and incidence of gout are increasing worldwide. Approximately 5.2% of Canadian males and 2.4% of Canadian females are affected by gout, and the incidence of this disease increases with age. Therefore, it is important for people with gout disease or at high risk of gout disease to monitor their level of uric acid. Within the frame of this proposal, we will perform a market analysis to identify the potential of our device to compete with existing technologies available on the market. Market size, user-derived design specifications will be obtained for interactions with end users. Once the market analysis is completed, we will decide on the next steps, such as to move to the next phase of pilot testing and prototyping, and starting up a company. Overall, if successful, the project will allow for the development of novel technology for individuals suffering from gout disease, leading to an improved quality of life and lower disability adjusted life years.